Developing a vaccine for HIV using advanced antibody analysis techniques
Scientific Core: Structural Proteomics
This study is working on creating a better vaccine for HIV by looking closely at how our immune system's antibodies react to the virus, using some really cool technology, to help design stronger treatments for people living with HIV.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scripps Research Institute, the NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11076794 on NIH RePORTER |
What this research studies
This research focuses on designing a vaccine for HIV by utilizing innovative techniques to analyze how antibodies respond to the virus. It employs advanced methods like single-cell RNA sequencing and electron microscopy to gain detailed insights into immune responses. By integrating these technologies, the research aims to identify specific antibody interactions with the virus, which could lead to more effective vaccine designs. The goal is to streamline the process of creating monoclonal antibodies that can target HIV effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at high risk for HIV infection or those living with HIV who may benefit from improved vaccine strategies.
Not a fit: Patients who are not at risk for HIV or those who are already receiving effective treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of a more effective HIV vaccine, improving prevention strategies for patients at risk of infection.
How similar studies have performed: Previous research has shown promising results in vaccine development using similar advanced immunological techniques, indicating a potential for success in this approach.
Where this research is happening
La Jolla, United States
- Scripps Research Institute, the — La Jolla, United States (Active)
Researchers
- Principal investigator: Ward, Andrew Barrett — Scripps Research Institute, the
- Study coordinator: Ward, Andrew Barrett
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.